206 articles
This presentation was delivered by Dr. Kalyan C. Kankanala as part of a course for senior management and IP officers in the automobile industry. It examines patentability requirements…
The Delhi High Court restrained Glenmark from manufacturing and marketing generic versions of Merck’s patented antidiabetic drugs. This case underscores key principles of Indian patent law and the…
This article analyses the evolution and practice of compulsory licensing in India, focusing on landmark cases and their effects on patent activity. It assesses whether compulsory licensing influences…
This article explores compulsory licensing in patents under Indian law, focusing on its impact on business strategies and public interest. Through case studies and legal analysis, the article…
A collective letter to the Prime Minister raises critical issues regarding the 2015 software patenting guidelines, citing potential harm to innovation and conflicts with Indian law. The post…
This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether…
This post analyses the Indian Patent Office’s rejection of Pfizer’s Tofacitinib patent under Section 3(d). The decision addresses issues of novelty, inventive step, and the requirement for evidence…
The post analyses whether the statement of working of patents in India truly advances public interest or remains a procedural formality. It argues that while mandatory, its enforcement…
This article analyses common patent myths and clarifies key aspects of patent law in India. It offers insights on patent eligibility, enforcement, and the importance of professional advice…
This post provides an analytical overview of pre-grant and post-grant opposition provisions in Indian patent law. It explains the procedural and substantive changes introduced by the Patents (Amendment)…